AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34272412 — intervention group
Group type: EXPERIMENTAL
Intervention: P-wave duration (PWD)
Number of subjects: 0
Study 34272412 — intervention group
Group type: EXPERIMENTAL
Intervention: N-terminal pro-brain natriuretic peptide (NT-pro BNP)
Number of subjects: 0
Study 34272412 — intervention group
Group type: EXPERIMENTAL
Intervention: PR interval
Number of subjects: 0
Study 35886296 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 150
Study 35886296 — intervention group
Group type: COMPARATOR
Intervention: Sham cognitive intervention
Number of subjects: 150
Study 35886296 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 150
Study 34593721 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized educational program (educational booklet + biweekly personalized counseling)
Number of subjects: 43
Study 34593721 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational booklet only)
Number of subjects: 43
Study 35473848 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational videos (n=35)
Number of subjects: 62
Study 35473848 — intervention group
Group type: COMPARATOR
Intervention: Non-informational videos (n=27)
Number of subjects: 62
Study 35473848 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos uploaded by professionals (n=54)
Number of subjects: 62
Study 35473848 — intervention group
Group type: COMPARATOR
Intervention: Videos uploaded by non-professionals (n=8)
Number of subjects: 62
Study 35473848 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall videos analyzed (n=62)
Number of subjects: 62
Study 33714860 — intervention group
Group type: EXPERIMENTAL
Intervention: SOX (100 mg/m2 of oxaliplatin on day 1 and 80 mg/m2/day of S‐1 on days 1‐14, every 21 days, eight cycles)
Number of subjects: 955
Study 33714860 — intervention group
Group type: COMPARATOR
Intervention: UFT/LV (300 mg/m2 of UFT and 75 mg/day of LV on days 1‐28, every 35 days, five cycles)
Number of subjects: 955
Study 33714860 — intervention group
Group type: EXPERIMENTAL
Intervention: SOX (in subgroup analysis for T4N2b disease)
Number of subjects: 955
Study 33714860 — intervention group
Group type: COMPARATOR
Intervention: UFT/LV (in subgroup analysis for T4N2b disease)
Number of subjects: 955
Study 32219623 — intervention group
Group type: EXPERIMENTAL
Intervention: MAKS treatment
Number of subjects: 433
Study 35753684 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency transcutaneous electric nerve stimulation (LF-TENS)
Number of subjects: 160
Study 35753684 — intervention group
Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 160
Study 34020641 — intervention group
Group type: EXPERIMENTAL
Intervention: 2–5 day corticosteroid regimen
Number of subjects: 632
Study 34020641 — intervention group
Group type: COMPARATOR
Intervention: 14-day corticosteroid regimen
Number of subjects: 632
Study 32175892 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement
Number of subjects: 1596
Study 32175892 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement in males
Number of subjects: 1596
Study 32175892 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement in females
Number of subjects: 1596
Study 32175892 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement for right hips
Number of subjects: 1596
Study 32175892 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement for left hips
Number of subjects: 1596
Study 32175892 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) limits for mild dysplasia
Number of subjects: 1596
Study 32175892 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) limits for severe dysplasia
Number of subjects: 1596
Study 32175892 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related increase in CEA values
Number of subjects: 1596
Study 35751307 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride 2 mg/kg bolus dose
Number of subjects: 40
Study 35751307 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline continuous intravenous infusion
Number of subjects: 40
Study 32797700 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracker needle switched on
Number of subjects: 40
Study 32797700 — intervention group
Group type: COMPARATOR
Intervention: Tracker needle switched off
Number of subjects: 40
Study 32797700 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle tip identification before injection
Number of subjects: 40
Study 32797700 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle tip identification before advance of the needle
Number of subjects: 40
Study 32797700 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure to identify the needle tip before injection
Number of subjects: 40
Study 32797700 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure to quickly regain needle tip position when visibility was lost
Number of subjects: 40
Study 36068075 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide group (computer-aided design and fully guided bone harvesting)
Number of subjects: 28
Study 36068075 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery without guide)
Number of subjects: 28
Study 33305520 — intervention group
Group type: EXPERIMENTAL
Intervention: Starting the Conversation (STC) intervention - 20‐min video, workbook, and resource guide
Number of subjects: 144
Study 33305520 — intervention group
Group type: COMPARATOR
Intervention: Control group - resource guide only
Number of subjects: 144
Study 35233704 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% NaOCl
Number of subjects: 40
Study 35233704 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl
Number of subjects: 40
Study 35233704 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl
Number of subjects: 40
Study 35233704 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study 34000964 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback (BFb)
Number of subjects: 32
Study 34000964 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 34583659 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based drug-use prevention program (10 sessions of 45 minutes each)
Number of subjects: 648
Study 34583659 — intervention group
Group type: COMPARATOR
Intervention: Traditional didactic teaching and drug refusal skill training
Number of subjects: 648
Study 34583659 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based drug-use prevention program
Number of subjects: 648
Study 32298326 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-week exercise intervention during chemotherapy
Number of subjects: 127
Study 32298326 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline physical fatigue
Number of subjects: 127
Study 32298326 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline total PA
Number of subjects: 127
Study 32298326 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline leisure and sport PA
Number of subjects: 127
Study 32298326 — intervention group
Group type: EXPERIMENTAL
Intervention: Recreational facilities within a buffer of 1 km
Number of subjects: 127
Study 32298326 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical fatigue at 4‐year follow‐up
Number of subjects: 127
Study 32298326 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in physical fatigue during the intervention period
Number of subjects: 127
Study 35770581 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise combined with Trigger Point Acupuncture (Ex+TrPAcp) for 3 months
Number of subjects: 15
Study 35770581 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone (Ex) for 3 months
Number of subjects: 15
Study 34879820 — intervention group
Group type: EXPERIMENTAL
Intervention: STI risk prediction tool with a cut-point of 23
Number of subjects: 1007
Study 34879820 — intervention group
Group type: EXPERIMENTAL
Intervention: STI risk prediction tool with a cut-point of 19
Number of subjects: 1007
Study 34879820 — intervention group
Group type: EXPERIMENTAL
Intervention: CT/NG testing
Number of subjects: 1007
Study 34879820 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factor questionnaire
Number of subjects: 1007
Study 33563037 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief educational intervention and contact program (BIC)
Number of subjects: 305
Study 33563037 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 305
Study 33563037 — intervention group
Group type: EXPERIMENTAL
Intervention: BIC
Number of subjects: 305
Study 33563037 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 305
Study 33228736 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (monthly intravenous methylprednisolone pulses or daily oral prednisolone)
Number of subjects: 130
Study 33228736 — intervention group
Group type: COMPARATOR
Intervention: Clobazam (oral)
Number of subjects: 130
Study 35848625 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application in addition to standard management (short counseling session and 1-month course of oral iron therapy)
Number of subjects: 382
Study 35848625 — intervention group
Group type: COMPARATOR
Intervention: Standard management (short counseling session and 1-month course of oral iron therapy)
Number of subjects: 382
Study 35848625 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application in addition to standard management
Number of subjects: 382
Study 35848625 — intervention group
Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 382
Study 34236436 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g OBG (oat β-glucan) 3 times daily for 4 weeks
Number of subjects: 191
Study 34236436 — intervention group
Group type: COMPARATOR
Intervention: Rice powder (Control)
Number of subjects: 191
Study 32152488 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin care (SSC)
Number of subjects: 100
Study 32152488 — intervention group
Group type: COMPARATOR
Intervention: Oral sucrose
Number of subjects: 100
Study 35697444 — intervention group
Group type: EXPERIMENTAL
Intervention: High egg and peanut diet (at least 6 eggs and 60 peanuts per week)
Number of subjects: 2136
Study 35697444 — intervention group
Group type: COMPARATOR
Intervention: Standard (low) egg and peanut diet (no more than 3 eggs and 30 peanuts per week)
Number of subjects: 2136
Study 35235030 — intervention group
Group type: EXPERIMENTAL
Intervention: Single injection IS nerve block of 10 cc (133 mg) liposomal bupivacaine mixed with 10 cc of 0.5% bupivacaine (Group 1)
Number of subjects: 76
Study 35235030 — intervention group
Group type: COMPARATOR
Intervention: Continuous indwelling IS nerve block catheter delivering 0.2% ropivacaine at a continual 4 cc/h infusion for the initial 3 post-operative days (Group 2)
Number of subjects: 76
Study 34427188 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary self‐monitoring via MyFitnessPal for approximately 1 month
Number of subjects: 200
Study 34427188 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 200
Study 32679537 — intervention group
Group type: COMPARATOR
Intervention: Optimised usual care: information package and family doctor follow‐up 6 months postpartum
Number of subjects: 480
Study 32679537 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention: information package plus assessment and brief LBC counselling at a specialised clinic with an obstetric physician and dietitian 6 months postpartum
Number of subjects: 480
Study 32679537 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended intervention: as per group 2 plus enrolment into a 6 month telephone‐based LBC program from 6 to 12 months postpartum
Number of subjects: 480
Study 35150880 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous posaconazole therapy followed by oral therapy (200 mg once daily after day 12)
Number of subjects: 23
Study 35150880 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral posaconazole therapy (400 mg twice daily on day 1, followed by 400 mg once daily)
Number of subjects: 23
Study 35150880 — intervention group
Group type: EXPERIMENTAL
Intervention: Posaconazole unbound fraction
Number of subjects: 23
Study 33052038 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic training (6 hours for ST group, 2 hours for MS group)
Number of subjects: 20
Study 33052038 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic training
Number of subjects: 20
Study 33052038 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic training (MS group)
Number of subjects: 20
Study 33052038 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic training (6 hours for ST group, 2 hours for MS group)
Number of subjects: 20
Study 33052038 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic training
Number of subjects: 20
Study 33052038 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic training (MS group)
Number of subjects: 20
Study 34293446 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine with a median of 3 concomitant antibiotics
Number of subjects: 44
Study 34293446 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine
Number of subjects: 44
Study 35410169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine local anesthesia
Number of subjects: 80
Study 35410169 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 80
Study 34534176 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic stimulation (N = 102)
Number of subjects: 204
Study 34534176 — intervention group
Group type: COMPARATOR
Intervention: Low-level sham stimulation (N = 102)
Number of subjects: 204
Study 34534176 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cohort after sham group switched to therapeutic stimulation
Number of subjects: 204
Study 34534176 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic stimulation
Number of subjects: 204
Study 32827227 — intervention group
Group type: EXPERIMENTAL
Intervention: COAL
Number of subjects: 10
Study 32827227 — intervention group
Group type: EXPERIMENTAL
Intervention: COAL/RT
Number of subjects: 10
Study 32827227 — intervention group
Group type: EXPERIMENTAL
Intervention: COAL/WT
Number of subjects: 10
Study 32827227 — intervention group
Group type: EXPERIMENTAL
Intervention: CP
Number of subjects: 10
Study 32827227 — intervention group
Group type: EXPERIMENTAL
Intervention: RT
Number of subjects: 10
Study 32827227 — intervention group
Group type: EXPERIMENTAL
Intervention: WT
Number of subjects: 10
Study 32827227 — intervention group
Group type: COMPARATOR
Intervention: CONT
Number of subjects: 10
Study 35572824 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Huayu Pinggan Zishen recipe combined with valsartan
Number of subjects: 100
Study 35572824 — intervention group
Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 100
Study 32525925 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy for 3 months
Number of subjects: 508
Study 32525925 — intervention group
Group type: COMPARATOR
Intervention: Single antiplatelet therapy
Number of subjects: 508
Study 34933066 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly hemodialysis with adjuvant pharmacologic therapy for 6 weeks followed by thrice-weekly hemodialysis (incremental HD group)
Number of subjects: 51
Study 34933066 — intervention group
Group type: COMPARATOR
Intervention: Thrice-weekly hemodialysis (conventional HD group)
Number of subjects: 51
Study 35593007 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder training (BT) + Magnetic stimulation (MStim)
Number of subjects: 76
Study 35593007 — intervention group
Group type: COMPARATOR
Intervention: Bladder training (BT) alone
Number of subjects: 76
Study 33390029 — intervention group
Group type: EXPERIMENTAL
Intervention: X-Bolt Hip System (XHS)
Number of subjects: 1128
Study 33390029 — intervention group
Group type: COMPARATOR
Intervention: Sliding hip screw (SHS)
Number of subjects: 1128
Study 36152982 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular aneurysm repair (EVAR)
Number of subjects: 350
Study 36152982 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 350
Study 34669886 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplementation (40 g daily for 15 days)
Number of subjects: 56
Study 34669886 — intervention group
Group type: COMPARATOR
Intervention: Casein supplementation (40 g daily for 15 days)
Number of subjects: 56
Study 34669886 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (WP and casein)
Number of subjects: 56
Study 34669886 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients meeting protein requirements with positive energy balance
Number of subjects: 56
Study 33243041 — intervention group
Group type: EXPERIMENTAL
Intervention: Caring intervention (physical activity, diet and counseling)
Number of subjects: 120
Study 33243041 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 33155296 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 0
Study 33155296 — intervention group
Group type: COMPARATOR
Intervention: OLS models estimating SACE for periodontal treatment
Number of subjects: 0
Study 36331050 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Ecosystem (CE)
Number of subjects: 490
Study 36331050 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 490
Study 33456346 — intervention group
Group type: EXPERIMENTAL
Intervention: Left stellate ganglion ablation (SGA)
Number of subjects: 20
Study 33456346 — intervention group
Group type: COMPARATOR
Intervention: Acute stroke (AS)
Number of subjects: 20
Study 33456346 — intervention group
Group type: COMPARATOR
Intervention: Sham-operated group
Number of subjects: 20
Study 32730122 — intervention group
Group type: COMPARATOR
Intervention: 0.05% NaF rinse
Number of subjects: 17
Study 32730122 — intervention group
Group type: COMPARATOR
Intervention: 0.2% NaF rinse
Number of subjects: 17
Study 32730122 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.32% NaF rinse
Number of subjects: 17
Study 32340530 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral mobile health (eHealth) plus health coach
Number of subjects: 150
Study 32340530 — intervention group
Group type: COMPARATOR
Intervention: eHealth only
Number of subjects: 150
Study 35893415 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cryostimulation (WBC)
Number of subjects: 43
Study 35893415 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary rehabilitation program without WBC
Number of subjects: 43
Study 32957348 — intervention group
Group type: EXPERIMENTAL
Intervention: LRCC5310 (Group I)
Number of subjects: 50
Study 32957348 — intervention group
Group type: COMPARATOR
Intervention: Control (Group II)
Number of subjects: 50
Study 34396714 — intervention group
Group type: EXPERIMENTAL
Intervention: iChoose (high intensity, parent-child dyads)
Number of subjects: 139
Study 34396714 — intervention group
Group type: COMPARATOR
Intervention: Family Connections (low intensity, parents only)
Number of subjects: 139
Study 32956960 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Talk Intervention (6-8 sessions)
Number of subjects: 62
Study 32956960 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Talk about the Children (2-3 sessions)
Number of subjects: 62
Study 32541504 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0
Study 32541504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34495425 — intervention group
Group type: EXPERIMENTAL
Intervention: OMDI 0.002% once daily (Group 1 and Group 2)
Number of subjects: 125
Study 34495425 — intervention group
Group type: EXPERIMENTAL
Intervention: OMDI 0.002% once daily + timolol 0.5% twice daily (Group 3)
Number of subjects: 125
Study 34495425 — intervention group
Group type: COMPARATOR
Intervention: Control group (timolol 0.5% twice daily)
Number of subjects: 125
Study 36464536 — intervention group
Group type: EXPERIMENTAL
Intervention: Popular opinion leader (POL)-led organizational intervention with 4 interactive workshops
Number of subjects: 263
Study 36464536 — intervention group
Group type: EXPERIMENTAL
Intervention: Popular opinion leader (POL)-led organizational intervention
Number of subjects: 263
Study 36464536 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (control)
Number of subjects: 263
Study 33591367 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT high-risk group
Number of subjects: 5233
Study 33591367 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 5233
Study 33591367 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 5233
Study 33591367 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe baseline disability
Number of subjects: 5233
Study 33591367 — intervention group
Group type: EXPERIMENTAL
Intervention: Very severe baseline disability
Number of subjects: 5233
Study 33591367 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosed depression/anxiety
Number of subjects: 5233
Study 33591367 — intervention group
Group type: COMPARATOR
Intervention: 1 nonconcordant process of care
Number of subjects: 5233
Study 33591367 — intervention group
Group type: COMPARATOR
Intervention: 2 nonconcordant processes of care
Number of subjects: 5233
Study 33591367 — intervention group
Group type: COMPARATOR
Intervention: 3 nonconcordant processes of care
Number of subjects: 5233
Study 32727483 — intervention group
Group type: EXPERIMENTAL
Intervention: Industrial PM2.5 exposure
Number of subjects: 7600
Study 32727483 — intervention group
Group type: EXPERIMENTAL
Intervention: Industrial SO2 exposure
Number of subjects: 7600
Study 32727483 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined industrial exposures (PM2.5, SO2, NO2)
Number of subjects: 7600
Study 32727483 — intervention group
Group type: EXPERIMENTAL
Intervention: Industrial NO2 exposure
Number of subjects: 7600
Study 32727483 — intervention group
Group type: COMPARATOR
Intervention: Regional overall PM2.5 exposure
Number of subjects: 7600
Study 35239416 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab plus axitinib
Number of subjects: 437
Study 35239416 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 437
Study 32065601 — intervention group
Group type: COMPARATOR
Intervention: No prehydration
Number of subjects: 523
Study 32065601 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate prehydration (250 mL of 1.4% sodium bicarbonate administered in a 1-hour infusion)
Number of subjects: 523
Study 35816479 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) - Internet-based intervention for 10 weeks
Number of subjects: 129